Cargando…
Pathogenesis and management of myocardial injury in coronavirus disease 2019
The outbreak of coronavirus disease 2019 (COVID‐19), caused by severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection, has become a major health crisis and a worldwide pandemic. COVID‐19 is characterized by high infectivity, long incubation period, diverse clinical presentations, and...
Autores principales: | Wei, Zhi‐Yao, Geng, Yong‐Jian, Huang, Ji, Qian, Hai‐Yan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Ltd
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7405025/ https://www.ncbi.nlm.nih.gov/pubmed/32683753 http://dx.doi.org/10.1002/ejhf.1967 |
Ejemplares similares
-
Dronedarone for the treatment of atrial fibrillation with concomitant heart failure with preserved and mildly reduced ejection fraction: a post‐hoc analysis of the ATHENA trial
por: Vaduganathan, Muthiah, et al.
Publicado: (2022) -
Nurse delivered lifestyle interventions in primary health care to treat chronic disease risk factors associated with obesity: a systematic review
por: Sargent, G M, et al.
Publicado: (2012) -
Using adipose‐derived mesenchymal stem cells to fight the metabolic complications of obesity: Where do we stand?
por: Mikłosz, Agnieszka, et al.
Publicado: (2022) -
Sex in human loving.
por: Berne, Eric
Publicado: (1970) -
Sex‐based differences in biomarkers, health status, and reverse cardiac remodelling in patients with heart failure with reduced ejection fraction treated with sacubitril/valsartan
por: Ibrahim, Nasrien E., et al.
Publicado: (2020)